Search

everythinglearnresearchcommunity

for

Search:↓

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

Divalproex sodium can sometimes worsen behavior in some patients.

Olanzapine reduces stress-related anxiety in rats when given acutely.

Lurasidone is effective for bipolar depression and schizophrenia, but more safety data is needed.

A teenage girl's excessive hair growth was caused by a medication for mania, but improved after stopping the medication.

Divalproex sodium can unexpectedly cause agitation and hyperactivity in some patients.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

5-ARI therapy may help prevent prostate cancer progression.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Dopamine agonists like pramipexole and ropinirole can cause reversible hair loss.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Setipiprant did not significantly improve hair growth in men with hair loss.

Paroxetine relieves pain by increasing allopregnanolone levels.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

Apremilast showed mixed results for treating severe alopecia areata.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Valproic acid is a more effective treatment for vomiting in Alexander disease than other medications, with few side effects.

Apremilast did not work for treating severe alopecia areata.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

The care model improved timely diagnosis and treatment for psoriasis and psoriatic arthritis.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.